Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database
This study evidences a substantial shift towards SLNB as the primary axillary surgery following NAT during the study period. This trend emphasizes a preference for less invasive procedures, likely due to the efficacy of neoadjuvant therapy in reducing axillary lymph node involvement.
Authors
- Jakob de Vries (ORCID: https://orcid.org/0000-0003-0710-7188)
- Kwok‐Leung Cheung (ORCID: https://orcid.org/0000-0003-2973-0755)
- Antonio Ponti (ORCID: https://orcid.org/0000-0002-0906-6431)
- Isabel T. Rubio (ORCID: https://orcid.org/0000-0003-0035-0679)
- Maria João Cardoso (ORCID: https://orcid.org/0000-0002-8137-3700)
- Antonio Esgueva (ORCID: https://orcid.org/0000-0002-8622-064X)
- Lorenza Marotti (ORCID: https://orcid.org/0000-0003-2229-0080)
- Mariano Tomatis (ORCID: https://orcid.org/0000-0003-0129-8104)
- Peter van Dam (ORCID: https://orcid.org/0000-0002-7366-2860)
Institutions
- Champalimaud Foundation (PT)
- University Medical Center Groningen (NL)
- University of Nottingham (GB)
- Royal Derby Hospital (GB)
- European Society of Hypertension (IT)
- Antwerp University Hospital (BE)
- Clinica Universidad de Navarra (ES)
- Piedmont Reference Center for Epidemiology and Cancer Prevention (IT)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1002/jso.70158
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00